See every side of every news story
Get Started
SubscribeLogin
SAG Awards
Olaf Scholz
Pope Francis
German Politics
Donald Trump
Ukraine War
Volodymyr Zelenskyy
Israel-Hamas Conflict
Hamas
Wrestling
Basketball
Elon Musk
Published • loading... • Updated

NAMSA Acquires the U.S. Medical Device Testing Operations of WuXi AppTec, Solidifying its Position as the Leader in MedTech Testing and Clinical Research

Summary by Financial Post
TOLEDO, Ohio -- NAMSA, a world-leading MedTech testing, clinical and regulatory consulting firm, announced today that it has entered into a definitive agreement to acquire the U.S. medical device testing operations of WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable the pharmaceutical and life science industries to advance discoveries and deliver groundbreaking treatments to patients.

6 Articles

All
Left
Center
Right
1
Financial PostFinancial Post

NAMSA Acquires the U.S. Medical Device Testing Operations of WuXi AppTec, Solidifying its Position as the Leader in MedTech Testing and Clinical Research

TOLEDO, Ohio -- NAMSA, a world-leading MedTech testing, clinical and regulatory consulting firm, announced today that it has entered into a definitive agreement to acquire the U.S. medical device testing operations of WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable the pharmaceutical and life science industries to advance discoveries and deliver groundbreaking treatments to patients.

·Canada
Read Full Article
Endpoints NewsEndpoints News

WuXi AppTec sells medical device testing unit; Layoffs at Notch Therapeutics

Plus, news about Neurizon: WuXi AppTec divests again: The company is selling its US medical device testing operations, including facilities in Minnesota and Georgia to medtech consulting firm NAMSA, according to ...

Read Full Article
Medical Alley AssociationMedical Alley Association

NAMSA Acquires the US Medical Device Testing Operations of WuXi AppTec - Medical Alley

NAMSA Solidifies Position as the Leader in MedTech Testing and Clinical Research TOLEDO, OHIO USA –—NAMSA, a world-leading MedTech testing, clinical and regulatory consulting firm, announced today that is has entered into a definitive agreement to acquire the U.S. medical device testing operations of WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable the pharmaceutical and life science indus…

Read Full Article
Medical Device NetworkMedical Device Network

NAMSA acquires WuXi AppTec’s US medical device testing facilities

NAMSA acquires WuXi AppTec's US-based medical device testing operations to strengthen its medtech clinical research testing capabilities.The post NAMSA acquires WuXi AppTec’s US medical device testing facilities appeared first on Medical Device Network.

Read Full Article
Medical Device News MagazineMedical Device News Magazine

NAMSA Acquires The U.S. Medical Device Testing Operations Of WuXi AppTec, Solidifying Its Position As The Leader In MedTech Testing And Clinical Research - Medical Device News Magazine

Under the agreement, NAMSA will acquire WuXi AppTec facilities in Minnesota and Georgia.

Read Full Article
pharmaceutical-technology.compharmaceutical-technology.com

JPM 2025: WuXi AppTec rebuffs concern about lower GLP-1 demand after Lilly’s low revenue forecast - Pharmaceutical Technology

Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmaceutical-technology.com broke the news in on Thursday, January 16, 2025.
Sources are mostly out of (0)

Similar News Topics

Business

Business

Layoffs

Layoffs

News
For You
Search
BlindspotLocal